Iterum Therapeutics plc (ITRMF) Treasury Shares (2017 - 2024)

Iterum Therapeutics' Treasury Shares history runs 8 years deep, the most recent figure standing at $16666.0 for Q1 2024.

• In Q1 2024, Treasury Shares fell 81.37% year-over-year to $16666.0; the TTM figure through Mar 2024 stood at $16666.0 (down 81.37% YoY), while the FY2023 annual figure was $16666.0, down 87.05% from the prior year.
• Treasury Shares for Q1 2024 stood at $16666.0, roughly flat from $16666.0 in the prior quarter.
• The five-year high for Treasury Shares was $1.9 million in Q2 2022, with the low at $16666.0 in Q4 2023.
• The 5-year median for Treasury Shares is $89439.0 (2023), against an average of $549947.7.
• The sharpest annual moves came in 2020 and 2023: Treasury Shares jumped 3221.96% in 2020, then plunged 97.92% in 2023.
• Iterum Therapeutics' Treasury Shares stood at $65527.0 in 2020, then slumped by 49.13% to $33333.0 in 2021, then jumped by 286.19% to $128728.0 in 2022, then plunged by 87.05% to $16666.0 in 2023, then changed by 0.0% to $16666.0 in 2024.
• Business Quant data shows ITRMF's Treasury Shares at $16666.0 in Q1 2024, $16666.0 in Q4 2023, and $33965.0 in Q3 2023.